Both Forth Bridges

CBH Health

Gaithersburg, MD

CBH Health Overview

Principal Investigators

  • Robert Litman, MD
    Board Certified Psychiatry
  • Khaled Khalafallah, MD
    Board Certified Psychiatry

Site Contact
Bart Azwalinsky


  • Schizophrenia (Acute and Stable)
  • Bipolar
  • Depression
  • Anxiety Disorder
  • Alzheimer’s Disease
  • Type 2 Diabetes


  • 20 bed inpatient unit
  • Clinical pharmacology unit
  • Outpatient clinic

Institutional Review Board

For Sponsors and CROs – Please Contact

News Feed

May, 2017: CBH Health moved into its new 20,000-square-foot facility in Gaithersburg, Md. toward the end of 2016. It consists of a secure 20-bed inpatient clinical research unit, and an outpatient unit with designated bed ward area. We have designated rooms for cognition testing. There is also an area for infusions (ketamine) that is used for both research and outpatient services. The building holds our recruitment and assessment team, administrative offices, research staff offices, monitoring space and additional exam rooms where our outpatient clients are seen for pharmacology management visits. Adjacent to these offices, there is a psychiatric rehabilitation program which sees clients that are diagnosed with schizophrenia, depression, and bipolar illness.

In 2016, CBH Health continued its early-phase biomarker collaborations with the University of Maryland/Maryland Psychiatric Research Center (UMD/MPRC). They completed a Phase Ib study in schizophrenia, enrolling 80 subjects in 10 months. In addition, CBH Health continued to be the highest enrolling site on their depression clinical trial, and began work on both acute and stable psychiatric studies for 2017.